Large-volume IM injections: A review of best practices
Intramuscular injections offer improved treatment adherence, ease in monitoring of adverse effects, and multiple administration sites.
Intramuscular (IM) injection is one of many routes for administering medications, includ-ing antibiotics, vaccines, hormonal therapies, and corticosteroids.1,2 Even when alternate routes …
FDA Approves Denosumab Biosimilars Ospomyv and Xbryk
Mar 20, 2025 · The Food and Drug Administration (FDA) has approved the Biologics License Applications (BLA) for Ospomyv ™ (denosumab-dssb; SB16; 60mg pre-filled syringe) and …
Page 51 – Oncology Nurse Advisor
Apr 6, 2015 · Investigators sought to determine the incidence of injection site reactions (ISRs) after administration of degarelix.
Epcoritamab Plus Rituximab Effective in High-Tumor-Burden …
Dec 11, 2025 · Treatment with rituximab plus epcoritamab has achieved rapid and deep responses in follicular lymphoma patients with a high tumor burden.
Corticosteroids for infusion reactions - Oncology Nurse Advisor
Dec 19, 2012 · Methylprednisolone (Solu-Medrol) and hydrocortisone (Solu-Cortef) are used to treat infusion reactions to chemotherapy and other anticancer treatments. Some clinicians …
Oxybutynin Effectively Reduced Hot Flashes in Men Undergoing ADT
Jun 11, 2024 · This clinical trial sought to determine the efficacy of oxybutynin in reducing the number of hot flashes experienced by men undergoing ADT for prostate cancer.
Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or …
Mar 23, 2017 · This research examines the lymphatic flow in the arm following breast cancer surgery and axillary lymph node dissection (ALND) versus sentinel lymph node biopsy (SLNB) …
Managing asparaginase-related toxicity in adult patients
Jan 14, 2011 · Asparaginase toxicity is a unique challenge in adult patients with ALL. Awareness and prompt management of its signs and symptoms will minimize risk and maximize drug …
Medicare guidelines for Aranesp and Procrit injections
May 24, 2013 · What are the new Medicare guidelines for the administration of an epoetin alfa injection (Procrit) or a darbepoetin alfa injection (Aranesp)?